Biotech stocks are gaining attention as the world emerges from the pandemic. These stocks are crucial due to their role in developing COVID-19 vaccines and boosters. Government institutions and traders are showing growing interest in the potential of biotech companies to provide solutions that could eradicate the virus.

For investors, now may be an opportune time to consider biotech stocks. By aligning their portfolios towards these companies, they could potentially achieve substantial financial gains, given the ongoing demand and research in biotechnology.